INCYTE CORP (INCY) Cost of Revenue USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Incyte Corp quarterly/annual Cost of Revenue history and growth rate from 2017 to 2024.
  • Incyte Corp Cost of Revenue for the quarter ending March 31, 2024 was $61 M, a 7.28% increase year-over-year.
  • Incyte Corp Cost of Revenue for the twelve months ending March 31, 2024 was $259 M, a 17.1% increase year-over-year.
  • Incyte Corp annual Cost of Revenue for 2023 was $255 M, a 23.2% increase from 2022.
  • Incyte Corp annual Cost of Revenue for 2022 was $207 M, a 37.1% increase from 2021.
  • Incyte Corp annual Cost of Revenue for 2021 was $151 M, a 15% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $259 M $61 M +$4.13 M +7.28% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $255 M $69.8 M +$10.6 M +17.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-13
Q3 2023 $244 M $60.1 M +$5.51 M +10.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $239 M $68.3 M +$17.7 M +34.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $221 M $56.8 M +$14.2 M +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $207 M $59.2 M +$15.3 M +34.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-13
Q3 2022 $192 M $54.6 M +$14.7 M +36.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $177 M $50.6 M +$12.6 M +33.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $164 M $42.6 M +$13.4 M +45.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $151 M $43.9 M +$7.55 M +20.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $143 M $39.9 M +$5.55 M +16.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $138 M $38 M +$4.66 M +14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $133 M $29.2 M +$1.9 M +6.96% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $131 M $36.3 M +$4.11 M +12.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-07
Q3 2020 $127 M $34.3 M +$4.28 M +14.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $123 M $33.4 M +$3.96 M +13.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $119 M $27.3 M +$4.73 M +20.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $114 M $32.2 M +$5.85 M +22.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-08
Q3 2019 $108 M $30 M +$5.25 M +21.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $103 M $29.4 M +$4.55 M +18.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $98.6 M $22.6 M +$4.48 M +24.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $94.1 M $26.4 M +$4.01 M +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $90.1 M $24.8 M +$2.76 M +12.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $87.4 M $24.9 M +$4.6 M +22.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $82.8 M $18.1 M +$3.28 M +22.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 $79.5 M $22.4 M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-13
Q3 2017 $22 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $20.3 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $14.8 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.